EP3508502
Samsetning af mótefnum gegn LAG-3 og mótefnum gegn PD-1 til að meðhöndla æxli
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.9.2014EP published:
26.4.2023EP application number:
18209399.7
EP translation filed:
17.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
17.9.2034Expiry date:
17.9.2026Next due date:
30.9.2026
Title in English:
COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORSLanguage of the patent:
English
Timeline
Today
18.9.2014EP application
26.4.2023EP Publication
17.8.2023Translation submitted
15.9.2023Registration published
17.9.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
KORMAN, Alan J.Address:
Redwood City, CA 94063, US
Name:
LONBERG, NilsAddress:
Redwood City, CA 94063, US
Name:
FONTANA, David J.Address:
Seattle, WA 98102, US
Name:
GUTIERREZ, Andres A.Address:
Princeton, NJ 08543, US
Name:
SELBY, Mark J.Address:
Redwood City, CA 94063, US
Name:
LEWIS, Katherine E.Address:
Seattle, WA 98102, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361880606 PDate:
20.9.2013Country:
US
Number:
201462014471 PDate:
19.6.2014Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 5.9.2023
Expires: 17.9.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.8.2024
Expires: 17.9.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.9.2025
Expires: 17.9.2026
Payer: Árnason Faktor ehf.